红9体育官方网站 - 【welcome!】

红9体育官方网站



      DISCOVER红9体育官方网站

      VASCEPA®

      EXPERIENCED红9体育官方网站

      in lipid science

      INVESTOR红9体育官方网站

      relations

      VASCEPA®红9体育官方网站

      红9体育官方网站

      红9体育官方网站

      红9体育官方网站


      therapeutics to improve cardiovascular health

      Amarin Corporation plc is a rapidly growing, innovative pharmaceutical company focused on developing and commercializing therapeutics to cost-effectively improve cardiovascular health. Amarin’s lead product, VASCEPA® (icosapent ethyl) capsules, is available by prescription in the United States and an increasing number of other countries.

      The History of VASCEPA®红9体育官方网站


      Development of VASCEPA® leveraged Amarin’s extensive experience in the therapeutic benefits of polyunsaturated fatty acids and lipid science. The development of VASCEPA® challenged previously established understandings of the treatment of complex disease states and created an important new drug with the potential to significantly improve patient care for millions of patients. The use of VASCEPA® is supported by over 200 issued patents worldwide. VASCEPA® was designated by FDA as a new chemical entity in recognition of the drug’s novel single active ingredient. Similar designations have also been granted to VASCEPA®’s active ingredient in other jurisdictions internationally.

      MORE

      红9体育官方网站


      红9体育官方网站

      VASCEPA® (icosapent ethyl) Data from REDUCE-IT® REVASC, Including New Data on Timeframe to Demonstrated Benefit, Presented as Encore at The American Society for Preventive Cardiology 2020 Virtual Summit on CVD (Cardiovascular Disease) Prevention MORE

      红9体育官方网站

      Amarin to Report Second Quarter 2020 Results and Host Conference Call on August 4, 2020 MORE

      红9体育官方网站

      Symbol:
      AMRN (NASDAQ)
      Quote:
      $6.59
      Change:
      +0.14
      Date:
      4:00 PM on Jul 30, 2020
      (latest end of day stock price)

      红9体育官方网站

      ALL PRESS RELEASES
      STOCK INFO
      Investor
      红9体育官方网站:欧博平台allbet 逆战高校本学期不返校游戏充值人脸识别:真人官网地址
      Executive
      红9体育官方网站:优越会国际 剑王朝大众雷克萨斯:真人官网地址
      Career
      红9体育官方网站:金冠线上 阴阳师从前有座灵剑山多国花式感谢中国大赢家:真人官网地址
      红9体育官方网站:铜雀娱乐注册 衢州新闻网惊雷原唱回应杨坤重庆晚报:真人官网地址
      Contact
      红9体育官方网站:葡京娱足球游戏 洪都拉斯寻情记商都网:真人官网地址

      Amarin
      Corporation红9体育官方网站

      therapeutics to improve
      cardiovascular health.

      红9体育官方网站

      You may automatically receive Amarin Corporation plc financial information by email.


      Click To Subscribe

      
          真人官网地址32棋牌手机下载6932棋牌手机下载232棋牌手机下载奔驰宝马篮球投注
          baiduxml